Breakthrough COVID-19 raises risk of health problems, death
November 23, 2021
Compared with people who never had COVID-19, those who had breakthrough infections had a 53% higher risk of death.
Regeneron’s antibody drug shows protection against COVID-19 for up to 8 months
November 10, 2021
Such immunity is particularly important for immunocompromised people and those not responding to vaccines.
Racial bias in pulse oximetry results confirmed
November 4, 2021
Black patients with respiratory failure had a statistically significantly higher risk of occult hypoxemia, compared with White patients.
U.K. study finds vaccinated people easily transmit Delta variant in households
October 29, 2021
The researchers underlined that did not weaken the argument for vaccination as the best way of reducing serious illness from COVID-19 and said booster shots were required.
Surgery needed in nearly half of appendicitis patients treated with antibiotics
October 26, 2021
“Substantial numbers of patients report a preference for antibiotics, even if appendectomy may ultimately be necessary.”
Death from COVID highly unlikely if vaccinated – unless old and sick
October 22, 2021
The average age of people who died despite being vaccinated was 85.
Valneva jumps on positive results for COVID-19 vaccine candidate
October 19, 2021
The vaccine generated similar seroconversion rates and slightly higher neutralizing antibody titers compared with AstraZeneca’s Vaxzevria.
EU finds J&J COVID shot possibly linked to another rare clotting condition
October 4, 2021
EMA said the new, possibly life-threatening VTE condition to be included on the J&J product label was separate from TTS.
Pfizer starts dosing patients in oral COVID-19 drug trial
September 2, 2021
Pfizer’s mid-to-late-stage trial in 1,140 participants would study the therapy PF-07321332 in combination with a low dose of ritonavir.
U.S. plans COVID-19 booster shots at 6 months instead of 8: WSJ
August 27, 2021
Approval of boosters for three COVID-19 shots being administered in the United States is expected in mid-September.